These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 350075)

  • 41. Interaction of salsolinol and tetrahydropapaveroline with catecholamines.
    Melchior CL
    Alcohol Clin Exp Res; 1979 Oct; 3(4):364-7. PubMed ID: 391089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Illicit heroin manufacturing byproducts: capillary gas chromatographic determination and structural elucidation of narcotine- and norlaudanosine-related compounds.
    Allen AC; Cooper DA; Moore JM; Gloger M; Neumann H
    Anal Chem; 1984 Dec; 56(14):2940-7. PubMed ID: 6524667
    [No Abstract]   [Full Text] [Related]  

  • 43. Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV.
    Myers RD; Critcher EC
    Pharmacol Biochem Behav; 1982 May; 16(5):827-36. PubMed ID: 6283568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebroventricular tetrahydropapaveroline infusions and ethanol consumption in the rat.
    Sinclair JD; Myers RD
    Subst Alcohol Actions Misuse; 1982; 3(1-2):5-24. PubMed ID: 6890240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
    Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
    Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
    Rees JN; Florang VR; Anderson DG; Doorn JA
    Chem Res Toxicol; 2007 Oct; 20(10):1536-42. PubMed ID: 17887726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of ethanol on dopamine metabolism in rat liver and brain.
    Tank AW; Weiner H
    Adv Exp Med Biol; 1977; 85A():473-83. PubMed ID: 920492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of a tetrahydroisoquinoline in phenylketonuria.
    Lasala JM; Coscia CJ
    Science; 1979 Jan; 203(4377):283-4. PubMed ID: 153583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethanol preference in rats: increased consumption after intraventricular administration of tetrahydropapaveroline.
    Clow A; Stolerman IP; Murray RM; Sandler M
    Neuropharmacology; 1983 Apr; 22(4):563-5. PubMed ID: 6856052
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of tetrahydropapaveroline and naltrexone on voluntary ethanol ingestion in rats.
    Oster L; Martinez TT
    Proc West Pharmacol Soc; 1988; 31():277-9. PubMed ID: 3211915
    [No Abstract]   [Full Text] [Related]  

  • 51. The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
    Rooke N; Li DJ; Li J; Keung WM
    J Med Chem; 2000 Nov; 43(22):4169-79. PubMed ID: 11063613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of acetaldehyde in the pathogenetic mechanisms of the development of chronic alcoholism].
    Sinitskiĭ VN; Kharchenko NK
    Fiziol Zh (1994); 1994; 40(3-4):94-100. PubMed ID: 7621963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amine-aldehyde metabolites and alcoholism: fact, myth or uncertainty.
    Myers RD; Melchior C; Swartzwelder HS
    Subst Alcohol Actions Misuse; 1980; 1(2):223-38. PubMed ID: 7197809
    [No Abstract]   [Full Text] [Related]  

  • 54. PHARMACOLOGICAL PROPERTIES OF TETRAHYDROPAPAVEROLINE AND THEIR RELATION TO THE CATECHOLAMINES.
    SANTI R; BRUNI A; LUCIANI S; TOTH CE; FERRARI M; FASSINA G; CONTESSA AR
    J Pharm Pharmacol; 1964 Apr; 16():287-8. PubMed ID: 14174934
    [No Abstract]   [Full Text] [Related]  

  • 55. Opiate receptor binding and analgesic effects of the tetrahydroisoquinolines salsolinol and tetrahydropapaveroline.
    Fertel RH; Greenwald JE; Schwarz R; Wong L; Bianchine J
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):3-16. PubMed ID: 6244607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical markers of a predisposition to alcoholism.
    Schuckit MA
    Contemp Issues Clin Biochem; 1984; 1():20-50. PubMed ID: 6400500
    [No Abstract]   [Full Text] [Related]  

  • 57. Half-lives of salsolinol and tetrahydropapaveroline hydrobromide following intracerebroventricular injection.
    Melchor CL; Mueller A; Deitrich RA
    Biochem Pharmacol; 1980 Feb; 29(4):657-8. PubMed ID: 7370056
    [No Abstract]   [Full Text] [Related]  

  • 58. Stereoselective enzymatic O-methylation of tetrahydropapaveroline and tetrahydroxyberbine alkaloids.
    Meyerson LR; Cashaw JL; McMurtrey KD; Davis VE
    Biochem Pharmacol; 1979 Jun; 28(11):1745-52. PubMed ID: 475835
    [No Abstract]   [Full Text] [Related]  

  • 59. Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde.
    Panoutsopoulos GI; Kouretas D; Gounaris EG; Beedham C
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):273-9. PubMed ID: 15569272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ethanol, salsolinol and tetrahydropapaveroline alter the discharge of neurons in several brain regions: comparison to opioid effects.
    Siggins GR; Berger T; French ED; Shier T; Bloom FE
    Prog Clin Biol Res; 1982; 90():275-87. PubMed ID: 6125947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.